December 9, 2021 Sophia Vida
Biotech & Pharma

AstraZeneca’s Covid Antibody Treatment Gets FDA Clearance for the Immunocompromised

This week the Food and Drug Administration (FDA) has given the green light to AstraZeneca’s Covid antibody treatment for immunocompromised individuals. The FDA has authorized the first injectable monoclonal antibody cocktail for long-term prevention of Covid-19 among people with weakened immune systems before they have been exposed to the coronavirus. Emergency use authorization was issued … Continue reading “AstraZeneca’s Covid Antibody Treatment Gets FDA Clearance for the Immunocompromised”